www.fdanews.com/articles/159649-jjs-janssen-companies-launch-a-trio-of-collaborations
J&J’s Janssen Companies Launch a Trio of Collaborations
October 7, 2013
Both Johnson & Johnson’s Janssen pharmaceuticals and biotech subsidiaries won contracts to develop or use other companies’ products in pursuit of therapies for rheumatoid arthritis, psoriasis and multiple sclerosis, as well as for vaccines.
Genetic Engineering & Bioechnology News
Genetic Engineering & Bioechnology News